Esquire Financial Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy

60

ESQ
Esquire Financial Holdings

Last Price:

$91.17

Seasonality Move:

4.9%

Sell

42

APLS
Apellis Pharmaceuticals

Last Price:

$18.84

Seasonality Move:

-0.62%

Buy

60

Esquire Financial Holdings (ESQ) is a Buy

Is Esquire Financial Holdings a Buy, Sell or Hold?

The current Esquire Financial Holdings [ESQ] share price is $91.23. The Score for ESQ is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
ESQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $18.83. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESQ Stock Price Chart

What is Esquire Financial Holdings's stock price today?

The Esquire Financial Holdings share price today is $91.23

The current trend is moderately bullish and ESQ is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $18.83

The current trend is relatively stagnant and APLS is experiencing slight selling pressure.

ESQ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.18	Buy
Relative Strength Index (14 RSI):	57.3	Buy
Chaikin Money Flow:	20018	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(89.1 - 91.5)	Buy
Bollinger Bands (100):	(76.07 - 89.33)	Buy

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.19	Buy
Relative Strength Index (14 RSI):	51.68	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(17.04 - 19.02)	Buy
Bollinger Bands (100):	(18.02 - 27.22)	Sell

ESQ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	90.77	Buy
20-day SMA:	90.35	Buy
50-day SMA:	85.73	Buy
200-day SMA:	76.31	Buy
8-day EMA:	91.12	Buy
20-day EMA:	89.83	Buy
50-day EMA:	79.67	Buy
200-day EMA:	38.34	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	19.15	Sell
20-day SMA:	18.27	Buy
50-day SMA:	18.45	Buy
200-day SMA:	27.26	Sell
8-day EMA:	19	Sell
20-day EMA:	18.61	Buy
50-day EMA:	19.47	Sell
200-day EMA:	27.34	Sell

Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.07 per share, an increase this year of $0.40 per share, and an increase next year of $0.53 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Esquire Financial Holdings Technical Analysis

	Jun 2	Jun 3	Jun 4	Jun 5	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13
	Jun
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Jun 2	Jun 3	Jun 4	Jun 5	Jun 6	Jun 9	Jun 10	Jun 11	Jun 12	Jun 13
	Jun
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):